“In Italy 52 thousand women with metastatic breast cancer”

2023-09-12 18:22:35

“Unfortunately, Italian women who will receive a diagnosis of breast cancer this year are 57 thousand. Fortunately, not all of them develop metastases, in fact 80% of them are disease-free after 10 years. However, there are also 52 thousand women we are treating for metastatic breast cancer.” These are the words of Saverio Cinieri, president of Aiom – Italian Association of Medical Oncology, on the sidelines of the press conference with which Astrazeneca and Daiichi Sankyo announced the reimbursement, granted by Aifa, for trastuzumab deruxtecan, a drug-conjugated monoclonal antibody for the treatment of HER2 positive metastatic breast cancer.